200 Participants Needed

Sleep Intervention for Teen Depression

LA
Overseen ByLauren Asarnow, PhD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: University of California, San Francisco
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines how improving sleep patterns can reduce depression in teenagers. It aims to align the body's natural clock with waking times through a cognitive-behavioral sleep program. Participants will receive either psychoeducation (educational therapy) or a new treatment called TranS-C (Transdiagnostic Sleep and Circadian Rhythm Intervention), which researchers are testing for effectiveness. Teens who may be suitable have depression and struggle with sleep timing, without recent medication changes or severe medical conditions. As an unphased trial, this study provides a unique opportunity for teens to explore innovative treatments that could enhance their mental health and sleep.

Will I have to stop taking my current medications?

The trial requires that participants do not use medications or herbs that affect sleep and have not changed medications in the last 8 weeks. If you are taking such medications, you may need to stop or adjust them before joining the trial.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that psychoeducation is generally safe and well-tolerated for teenagers with depression. Studies have found that it can help teens adhere to their treatment plans and improve their social interactions. When teens receive psychoeducational support, they are more likely to follow their treatment and engage better in social activities.

Specific safety data for TranS-C is not available in the sources. However, since this trial is not in its early stages, the treatment is likely considered safe enough for testing with more participants. Researchers believe TranS-C could be safe for participants, but discussing any concerns with the trial team is always important.

In summary, current evidence supports the safety of psychoeducation. While specific data for TranS-C is lacking, its inclusion in this trial suggests it might be safe for teenagers. Always consult the trial staff to understand the risks and benefits before deciding to join.12345

Why are researchers excited about this trial?

Researchers are excited about the Sleep Intervention for Teen Depression trial because it explores innovative approaches to managing depression in adolescents. Unlike traditional treatments like antidepressants and talk therapy, this trial investigates psychoeducation and TranS-C (Transdiagnostic Sleep and Circadian Intervention). TranS-C is particularly exciting because it focuses on improving sleep and regulating the body's internal clock, which are often disrupted in depression. By addressing sleep and circadian rhythms, TranS-C may offer a new pathway to alleviate depressive symptoms without the side effects associated with medication. This approach could provide a valuable alternative or complement to existing treatments, especially for teens who struggle with sleep issues alongside depression.

What evidence suggests that this trial's treatments could be effective for teen depression?

In this trial, participants will join one of two treatment arms. Research has shown that psychoeducation, one of the treatments under study, can help treat depression in teenagers. It increases the likelihood that teens will adhere to their treatment plans and can enhance their social and personal functioning.

The other treatment arm will examine TranS-C, a program addressing sleep and body clock issues. TranS-C has shown promising results in reducing depression in teens by aligning body clocks, improving sleep quality, and reducing sleep difficulties. Studies have demonstrated that TranS-C leads to better sleep and overall well-being. Both treatments focus on different approaches to managing depression and offer potential benefits for teens facing this condition.13678

Are You a Good Fit for This Trial?

This trial is for adolescents with depression and misaligned sleep patterns, who are stable in their medical/psychiatric condition and not on medications or herbs affecting sleep. Those with active psychosis, bipolar disorder, drug dependence, or severe conditions like terminal cancer cannot join.

Inclusion Criteria

Not applicable.

Exclusion Criteria

I do not have any severe health or mental conditions that would stop me from following the study's procedures.
I have changed my medication recently or plan to.
I am currently taking medication or herbs that affect my sleep.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a cognitive-behavioral sleep intervention to improve circadian rhythm alignment

2 months

Follow-up

Participants are monitored for changes in depression severity and circadian alignment

12 months

What Are the Treatments Tested in This Trial?

Interventions

  • Psychoeducation
  • TranS-C
Trial Overview The study tests if aligning biological circadian timing with wake time using a cognitive-behavioral sleep intervention can improve depression in adolescents. It's a confirmatory efficacy trial focused on this novel treatment target.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: TranS-CExperimental Treatment1 Intervention
Group II: PsychoeducationActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials
2,636
Recruited
19,080,000+

Stanford University

Collaborator

Trials
2,527
Recruited
17,430,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Published Research Related to This Trial

In a study involving 41 youth aged 12-20, combining cognitive behavioral therapy for insomnia (CBT-I) with standard depression treatment (CBT-D) led to significant improvements in sleep and depression outcomes, including a 99-minute increase in total sleep time by week 12.
The experimental group receiving CBT-I showed faster recovery rates and a higher percentage of participants recovering from depression compared to those receiving only sleep hygiene control, indicating that addressing sleep issues can enhance depression treatment effectiveness.
Cognitive-behavioral treatment of insomnia and depression in adolescents: A pilot randomized trial.Clarke, G., McGlinchey, EL., Hein, K., et al.[2018]
The TranS-C cognitive behavioral sleep intervention significantly reduced the severity of Major Depressive Disorder (MDD) in adolescents with evening circadian preference, showing lasting effects up to 12 months after treatment.
Improved alignment between circadian biology and sleep-wake behavior was identified as a key mechanism for the reduction in depression symptoms, suggesting that addressing sleep patterns can be crucial in treating depression in adolescents.
Report from a randomized control trial: improved alignment between circadian biology and sleep-wake behavior as a mechanism of depression symptom improvement in evening-type adolescents with depressive symptoms.Asarnow, LD., Soehner, A., Dolsen, E., et al.[2023]
Emerging evidence indicates that sleep difficulties in adolescents may precede the onset of depression, suggesting a complex relationship where sleep issues can contribute to the development of depressive symptoms.
The review highlights various contributors to sleep problems in adolescents, such as delayed circadian rhythms and restricted sleep duration, and recommends evidence-based interventions like bright light therapy and cognitive-behavioral techniques to improve sleep and alleviate depression symptoms.
Sleep's role in the development and resolution of adolescent depression.Gradisar, M., Kahn, M., Micic, G., et al.[2022]

Citations

Psychoeducational interventions in adolescent depressionFindings from a recent systematic review concluded that PIs are effective in improving the clinical course, treatment adherence, and psychosocial functioning of ...
Effects of Psychotherapy for Depression in Children and ...Overall, the mean effect size generated by treatments for youth depression was 0.34, averaging across all of the studies. This value lies about midway between ...
Evidence-Base Update of Psychosocial and Combination ...Results showed no significant difference between the treatment conditions, although both treatments showed positive within-group effects in ...
Psychoeducation as an adjunctive treatment for depressionPsychoeducation (PE) demonstrates potential as an adjunctive psychosocial treatment for Major Depressive Disorder(MDD) in patients during depressive episodes.
Finding Relevant Psychoeducation Content for ...Prior Work. According to previous studies, psychoeducation seems to be effective in treating depression, although as an integral component of ...
Diagnosis and management of depression in adolescentsWe review the diagnosis and management of depression in adolescents, drawing on available evidence and recommendations from international guidelines.
Depression in Children and Adolescents: Evaluation and ...Evidence from a good-quality randomized trial suggests that adolescents are most likely to achieve remission with 12 weeks of combined therapy ...
Treatment Outcomes of an Adolescent Intensive Outpatient ...Studies of youth attending a nationwide remote-only DBT- and CBT-informed IOP have demonstrated high attendance rates and significant reductions in depression, ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security